Chemotherapy for Colorectal Cancer Liver Metastases
作者： Steven R. Alberts , Lawrence D. Wagman
DOI: 10.1634/THEONCOLOGIST.2008-0142
关键词:
摘要: … Radical (R0) resection rates in patients with initially unresectable metastatic colorectal cancer treated with FOLFIRI or FOLFOXIRI chemotherapy in a randomized phase III study [36, 37]. …
elsevier.com
alphamedpress.org
oup.com参考文章(79)
Nancy Kemeny, Management of liver metastases from colorectal cancer. Oncology. ,vol. 20, pp. 1161- 1179 ,(2006)
Lian-Xin Liu, Wei-Hui Zhang, Hong-Chi Jiang, Current treatment for liver metastases from colorectal cancer World Journal of Gastroenterology. ,vol. 9, pp. 193- 200 ,(2003) , 10.3748/WJG.V9.I2.193
B. Nordlinger, H. Sorbye, L. Collette, B. Glimelius, G. J. Poston, P. M. Schlag, P. Rougier, W. Bechstein, E. Walpole, T. Gruenberger, Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases Journal of Clinical Oncology. ,vol. 25, ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.LBA5
D. Hollis, S. Sutherland, R. Goldberg, S. Alberts, A. Benson, J. Wade, R. Schilsky, R. Mayer, A. Venook, D. Niedzwiecki, Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) ± cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results Journal of Clinical Oncology. ,vol. 24, pp. 3509- 3509 ,(2006) , 10.1200/JCO.2006.24.18_SUPPL.3509
Matthias Lorenz, Hans-Helge Müller, , Randomized, Multicenter Trial of Fluorouracil Plus Leucovorin Administered Either Via Hepatic Arterial or Intravenous Infusion Versus Fluorodeoxyuridine Administered Via Hepatic Arterial Infusion in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma Journal of Clinical Oncology. ,vol. 18, pp. 243- 243 ,(2000) , 10.1200/JCO.2000.18.2.243
G. Biasco, E. Derenzini, GL. Grazi, G. Ercolani, M. Ravaioli, M.A. Pantaleo, G. Brandi, Treatment of hepatic metastases from colorectal cancer: Many doubts, some certainties Cancer Treatment Reviews. ,vol. 32, pp. 214- 228 ,(2006) , 10.1016/J.CTRV.2005.12.011
Gregory D. Leonard, Baruch Brenner, Nancy E. Kemeny, Neoadjuvant Chemotherapy Before Liver Resection for Patients With Unresectable Liver Metastases From Colorectal Carcinoma Journal of Clinical Oncology. ,vol. 23, pp. 2038- 2048 ,(2005) , 10.1200/JCO.2005.00.349
Felix G. Fernandez, John Ritter, J. Wendell Goodwin, David C. Linehan, William G. Hawkins, Steven M. Strasberg, Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases Journal of The American College of Surgeons. ,vol. 200, pp. 845- 853 ,(2005) , 10.1016/J.JAMCOLLSURG.2005.01.024
Nancy Kemeny, Ying Huang, Alfred M. Cohen, Weiji Shi, John A. Conti, Murray F. Brennan, Joseph R. Bertino, Alan D.M. Turnbull, Deidre Sullivan, Jennifer Stockman, Leslie H. Blumgart, Yuman Fong, Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer New England Journal of Medicine. ,vol. 341, pp. 2039- 2048 ,(1999) , 10.1056/NEJM199912303412702
Bernard Nordlinger, Marguerite Guiguet, Jean-Christophe Vaillant, Pierre Balladur, Karim Boudjema, Philippe Bachellier, Daniel Jaeck, Association Française de Chirurgie, Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients Cancer. ,vol. 77, pp. 1254- 1262 ,(1996) , 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I